Fetal bovine serum illegal entry intercepted, "domestic + no serum" is the way to go

Recently, the media reported that the staff of Shenzhen Bay Inspection and Quarantine Bureau intercepted fetal bovine serum in the luggage carried by incoming passengers, and it is not uncommon for the fetal bovine serum to be intercepted upon illegal entry.

(Image from the Internet)

Fetal bovine serum is used in professional experiments and research, containing amino acids, vitamins, inorganic substances, and lipids necessary for cell growth and other essential nutrients for cell growth. It is often used as an important additive with the base medium for cell culture. Its performance advantages are inseparable from the unique structure and design of fetal bovine serum. However, the price is high, up to 2000-3000 RMB per bottle in China. Driven by interest, individual watermen conceal it in batches in their luggage and bring it into the country to make high profits.

Animal cell culture is an indispensable part of pre-clinical in vitro experiments, playing an important role in vaccines, monoclonal antibodies, and cell therapy. With the high priority given to the biomedical industry in China and the support of several national and local policies, animal cell culture has great potential. The global prevalence of the large-scale culture of animal cells with bioreactors has reached more than 80%, all using personalized media, whose sales account for 70-90% of the world's major media manufacturers. Today, serum-free medium without animal-derived components is gradually replacing serum-based medium. Currently, China's biopharmaceutical industry is highly dependent on imports of general-purpose media in cell culture, and there is a lack of personalized serum-free media for customization. In the future, the serum-free and localization of animal cell culture media will become a critical path.

BioEngine relies on the technology and talent advantages of the State Key Laboratory of Bioreactor Engineering of East China University of Science and Technology and Zhangjiang Research Institute of East China University of Science and Technology to provide "one-stop" services for leading biopharmaceutical companies producing antibody drugs, human and poultry virus vaccines and medical institutions engaged in cell therapy and human tissue engineering. At the same time, BioEngine can provide customized personalized media, microcarriers, and other key raw materials closely related to the cell culture process for service companies. The company has built a pilot production base for the localization of raw materials for personalized culture media, breaking through the key technical bottleneck of serum-free culture media manufacturing, and laying the foundation for the production of serum-free localized culture media. In 2017, BioEngine was awarded the ISO:13485 quality management system certification by the European Union, becoming the first culture media manufacturer in China to obtain this certification. (www.bio-engine.com.cn)